GBP1 and glioblastoma: In contrast, GBP1 expression was elevated in tumor samples of esophageal carcinoma (ESCA) (p < 0.001), glioblastoma multiforme (GBM) (p < 0.001), kidney renal clear cell carcinoma (KIRC) (p < 0.001), stomach adenocarcinoma (STAD) (p < 0.001), and head and neck squamous cell carcinoma (HNSC) (p < 0.001).